CMS announced a proposed decision to cover transcatheter tricuspid valve replacement (TTVR) for Medicare beneficiaries.

Over the past 12 months, a number of medtech companies at various stages hauled in significant funding rounds to support ...

Roivios announced that it received FDA investigational device exemption (IDE) approval to conduct a trial for its renal ...

With approval, the company can begin commercializing the device in the U.S. in 2025.

Onward Medical announced today that it received FDA de novo clearance for its ARC-EX spinal cord stimulation (SCS) system.

Andromeda Surgical announced that a surgeon performed a robotic-assisted holmium laser enucleation of the prostate (HoLEP) ...

[Image courtesy of Smith+Nephew] Smith+Nephew (NYSE: SNN) + announced today that it received FDA clearance for its Coriograph pre-op planning and modeling services. The London-based orthopedic ...

[Image courtesy of Dexcom/Oura] Oura announced today that it completed a $200 million Series D funding round that included Dexcom (Nasdaq:DXCM). The investment comes as part of a new health ...

The POLARx cryoablation system. [Image courtesy of Boston Scientific] The FDA issued a notice alerting customers to updates made by Boston Scientific (NYSE: BSX) + to its PolarX cryoablation ...